Stockreport

BRIEF-Summit Completes Dosing Of Ezutromid In Phaseout Dmd Clinical Trial [Reuters]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF BRIEF-Summit Completes Dosing Of Ezutromid In Phaseout Dmd Clinical Trial | Reuters Reuters Staff 1 Min Read April 19 (Reuters) - Summit Therapeutics PLC: * SUMMIT COMPL [Read more]